NSE: EMAMILTD | BSE: 531162

Mid-range Performer

Download real time

573.60 6.15 (1.08%)

High vol. this week

NSE 29 Aug, 2025 3:31 PM (IST)

25,037.6

Market Cap

Below industry Median

0.6

Beta 1Year

Very Low volatility

Emami Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EMAMILTD, BSE:531162 Emami Ltd.

Emami Ltd.

08 Nov 2024

573.60

1.08%

Muted Q2, strong winter to boost H2

Buy: Emami Ltd.

Target

Sharekhan

Emami’s Q2FY2025 operating performance missed the mark with domestic volume growth coming at 1.7% versus expectations of 3-4%. Consolidated OPM came in-line at 28.1%.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

16 Sep 2024

573.60

1.08%

Emkay Connect: Shifting gears, from traditional to new-age users

Buy: Emami Ltd.

Recommendation Target

Emkay

We hosted Emami’s management team—Mohan Goenka (Director), Manish Gupta (Head of Sales), and Rajesh Sharma (Sr VP finance and IR)—and a group of investors, as part of our Emkay Connect initiative.

Emami Ltd. is trading below all available SMAs

Emami Ltd.

29 Aug 2024

573.60

1.08%

Rural demand and a hot summer drive sales momentum

Buy: Emami Ltd.

Target

Khambatta Securities

Emami’s healthy sales growth during the quarter is attributable to robust domestic volume growth and a hot summer. Demand witnessed a sequential improvement in the 1Q FY25, particularly in rural markets, as the company also launched 8 new products.

Khambatta Securities decreased Buy price target of Emami Ltd. to 698.0 on 26 Aug, 2025.

Emami Ltd.

01 Aug 2024

573.60

1.08%

Operationally in line; volume improvement continues

Buy: Emami Ltd.

Target

Motilal Oswal

Emami reported 10% YoY sales growth in 1QFY25 (est. 8%). The domestic business grew 10% YoY, led by 9% volume growth. There was a sequential improvement in demand in the rural market.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

29 May 2024

573.60

1.08%

Good Q4; growth momentum to improve in FY25

Buy: Emami Ltd.

Target

Sharekhan

Emami’s Q4FY2024 operating performance was good as compared to the earlier quarter with a 6.4% volume growth; revenue grew by 7%; EBIDTA margin stood stable at 23.7%.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

06 Nov 2023

573.60

1.08%

Volume muted; rural recovery essential

Buy: Emami Ltd.

Target

Motilal Oswal

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

06 Nov 2023

573.60

1.08%

Emami

Buy: Emami Ltd.

Target

Sharekhan

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

08 Aug 2023

573.60

1.08%

Some tailwinds and many execution improvements

Accumulate: Emami Ltd.

Target

ICICI Securities Limited

Emami reported robust double-digit growth (+16% YoY) in non-summer portfolio, while summer portfolio was impacted by unseasonal rains in key markets. Growth was driven by the return of double-digit growth in pain management and healthcare range which is encouraging. Scale-up of Dermicool (+9% YoY) is also progressing well with the launch of new campaign and LUP SKUs to induce consumer trials.

Emami Ltd. has lost -29.46% in the last 1 Year

Emami Ltd.

08 Aug 2023

573.60

1.08%

In-line performance; margin improving

Buy: Emami Ltd.

Target

Motilal Oswal

Number of FII/FPI investors increased from 337 to 349 in Jun 2025 qtr.

Emami Ltd.

26 May 2023

573.60

1.08%

Weak performance continues across the board

Accumulate: Emami Ltd.

Target

ICICI Securities Limited

Emami reported a patchy revenue performance with (consol.) adjusted revenue (explained below) decline of ~2% YoY. Weak performance was due to subdued rural demand (some green shoots in current quarter) and unseasonal rains.

Emami Ltd. has lost -29.46% in the last 1 Year

Is Emami Ltd. worth buying?

224 Votes:

Buy 74.55%

Sell 17.41%

Hold 8.04%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf